Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

305 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Risk-adapted letermovir prophylaxis based on a scoring system predicting a higher burden of cytomegalovirus exposure after allogeneic hematopoietic cell transplantation.
Kawamura S, Fujiwara SI, Kimura SI, Takeshita J, Nakasone H, Yoshimura K, Nakata Y, Ishikawa T, Matsuoka A, Meno T, Nakamura Y, Kawamura M, Yoshino N, Misaki Y, Gomyo A, Kusuda M, Murahashi R, Umino K, Minakata D, Ashizawa M, Yamamoto C, Hatano K, Sato K, Ohmine K, Kako S, Kanda Y. Kawamura S, et al. Among authors: kako s. Transplant Cell Ther. 2025 Jan 17:S2666-6367(25)00911-X. doi: 10.1016/j.jtct.2025.01.883. Online ahead of print. Transplant Cell Ther. 2025. PMID: 39828058
Comparing de novo chronic myeloid leukemia in blastic phase with Philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation.
Okada Y, Tachi N, Shimazu Y, Murata M, Nishiwaki S, Onishi Y, Jinguji A, Uchida N, Tanaka M, Hasegawa Y, Ito A, Kako S, Nishida T, Onodera K, Sawa M, Nakamae H, Toyosaki M, Kanda Y, Onizuka M, Fukuda T, Ohbiki M, Atsuta Y, Arai Y, Tachibana T. Okada Y, et al. Among authors: kako s. Cancer. 2025 Jan 1;131(1):e35627. doi: 10.1002/cncr.35627. Epub 2024 Nov 4. Cancer. 2025. PMID: 39497254
Superior Survival After Unrelated Allogeneic Stem Cell Transplantation With Low-Dose ATG Compared to Low-Dose TBI in Myeloablative Fludarabine/Busulfan-Based Regimen for MDS on Behalf of the Adult MDS Working Group of the JSTCT.
Fujioka M, Itonaga H, Nakazawa H, Nishida T, Kataoka K, Ikeda T, Kako S, Matsuoka KI, Adachi K, Fujiwara SI, Aotsuka N, Kawakita T, Sakaida E, Kanda Y, Ichinohe T, Atsuta Y, Miyazaki Y, Ishiyama K. Fujioka M, et al. Among authors: kako s. Transplant Cell Ther. 2025 Jan;31(1):18.e1-18.e12. doi: 10.1016/j.jtct.2024.09.026. Epub 2024 Oct 6. Transplant Cell Ther. 2025. PMID: 39374663
Haploidentical transplantation with post-transplant cyclophosphamide versus single cord blood transplantation in adults with relapsed/refractory non-Hodgkin lymphoma.
Nishikubo M, Shimomura Y, Nakaya Y, Shinohara A, Uchida N, Takayama N, Kobayashi H, Uehara Y, Ishikawa J, Ishiwata K, Hiramoto N, Nakazawa H, Kataoka K, Kanda J, Nagafuji K, Kozai Y, Matsuhashi Y, Ishimaru F, Kim SW, Fukuda T, Kanda Y, Atsuta Y, Kondo E, Kako S. Nishikubo M, et al. Among authors: kako s. Bone Marrow Transplant. 2024 Dec;59(12):1735-1743. doi: 10.1038/s41409-024-02423-y. Epub 2024 Sep 25. Bone Marrow Transplant. 2024. PMID: 39322651
Reduced-intensity conditioning with fludarabine/busulfan versus fludarabine/low-dose melphalan in patients with non-Hodgkin lymphoma undergoing allogeneic haematopoietic stem cell transplantation.
Kamijo K, Shimomura Y, Kim SW, Ohigashi H, Ishikawa J, Eto T, Hiramoto N, Mizuno I, Iida S, Ueda Y, Matsuoka KI, Yakushijin K, Mori Y, Onizuka M, Fukuda T, Atsuta Y, Kako S. Kamijo K, et al. Among authors: kako s. Br J Haematol. 2024 Sep;205(3):1097-1107. doi: 10.1111/bjh.19651. Epub 2024 Jul 24. Br J Haematol. 2024. PMID: 39049594
Clinical impact of a change in antibiotics or the addition of glycopeptide antibiotics for persistent febrile neutropenia after autologous stem cell transplantation.
Yoshino N, Kimura SI, Kawamura K, Nakata Y, Matsuoka A, Ishikawa T, Meno T, Nakamura Y, Kawamura M, Kawamura S, Takeshita J, Misaki Y, Yoshimura K, Gomyo A, Okada Y, Tamaki M, Kusuda M, Kameda K, Akahoshi Y, Sato M, Tanihara A, Nakasone H, Kako S, Kanda Y. Yoshino N, et al. Among authors: kako s. J Infect Chemother. 2025 Jan;31(1):102455. doi: 10.1016/j.jiac.2024.06.018. Epub 2024 Jun 24. J Infect Chemother. 2025. PMID: 38925426
Decision analysis for transplant candidates with primary myelofibrosis in the ruxolitinib era.
Okada Y, Nakasone H, Kawamura S, Takano K, Yoshimura K, Tamaki M, Matsuoka A, Ishikawa T, Meno T, Nakamura Y, Kawamura M, Takeshita J, Yoshino N, Misaki Y, Kusuda M, Tanihara A, Kimura SI, Kako S, Kanda Y. Okada Y, et al. Among authors: kako s. Haematologica. 2024 Nov 1;109(11):3593-3601. doi: 10.3324/haematol.2024.285256. Haematologica. 2024. PMID: 38899343 Free PMC article.
Metabolic Resistance and Not Voltage-Gated Sodium Channel Gene Mutation Is Associated with Pyrethroid Resistance of Aedes albopictus (Skuse, 1894) from Cambodia.
Marcombe S, Doeurk B, Thammavong P, Veseli T, Heafield C, Mills MA, Kako S, Prado MF, Thomson S, Millett S, Hill T, Kentsley I, Davies S, Pathiraja G, Daniels B, Browne L, Nyamukanga M, Harvey J, Rubinstein L, Townsend C, Allen Z, Davey-Spence C, Hupi A, Jones AK, Boyer S. Marcombe S, et al. Among authors: kako s. Insects. 2024 May 15;15(5):358. doi: 10.3390/insects15050358. Insects. 2024. PMID: 38786914 Free PMC article.
The impact of daratumumab pretreatment on multiple myeloma patients undergoing autologous transplantation.
Shimazu Y, Kanda J, Suzuki K, Wada A, Kikuchi T, Ikeda T, Tsukada N, Miwa A, Itagaki M, Kako S, Nishiwaki K, Ota S, Fujiwara SI, Kataoka K, Doki N, Sawa M, Hiramoto N, Nishikawa A, Imai T, Ichinohe T, Kanda Y, Atsuta Y, Kawamura K. Shimazu Y, et al. Among authors: kako s. Cancer Sci. 2024 Jul;115(7):2384-2395. doi: 10.1111/cas.16198. Epub 2024 May 16. Cancer Sci. 2024. PMID: 38757410 Free PMC article.
305 results